My Grief - an App for Parents With Prolonged Grief After Losing a Child to Cancer

May 9, 2023 updated by: Josefin Sveen, Uppsala University

My Grief - Development and Evaluation of an App for Parents With Prolonged Grief Disorder After Losing a Child to Cancer: a Randomized Controlled Trial

Bereaved parents are at increased risk of developing mental and physical health problems and bereavement is even associated with an increased risk of mortality, especially in mothers. Prolonged grief disorder (PGD) are persistent and intensive grief reactions which can persist for years. It is characterized by an intense and lasting yearning for the deceased, intense emotional pain, such as difficulty accepting the loss and an inability to experience positive mood. Parents are among the most vulnerable to develop PGD.

The goal is to increase the accessibility to evidence-based and cost-effective interventions for parents of children who have died of cancer, and thus facilitate the grieving process and decrease the risk for parents to develop long-term distress.

Specific aims are:

  • To evaluate the acceptability and feasibility of a mobile app, "My Grief ", a self-help app for prolonged grief, in parents who lost a child to cancer.
  • To evaluate possible beneficial effects of the mobile app on parents' mental health.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

There is a lack of studies evaluating the effect of interventions for bereaved parents. Thus, there is a need for accessible interventions with documented efficacy for preventing or reducing negative mental health consequences after the loss of a child. Today, many individuals carry smartphones and these devices can be used to access self-help interventions aiming to improve both physical and mental health. Currently, there are an excess of apps available for smartphone users that assert that they help people with their physical or mental health. However, for most of these apps, there is a lack of empirical support, i.e., their efficacy is unknown. It is therefore important to evaluate mobile apps in scientific studies with rigorous designs. In addition, before conducting rigorous studies of novel psychosocial interventions, such as a mobile app, it is important to conduct more basic work evaluating development and feasibility of the intervention. One such self-help app, the PTSD Coach, has been evaluated in a randomized controlled trial conducted with traumatized participants recruited from the community, which found that access to the PTSD Coach app was associated with improvements in posttraumatic stress (PTS) symptoms, depression, and psychosocial functioning. The PTSD Coach app is based on cognitive behavioural therapy (CBT) principles and there is a growing body of evidence that elements of CBT are effective interventions for prolonged grief. Thus, an app targeting prolonged grief using elements of CBT could potentially be effective in improving the mental health in bereaved parents. To our knowledge no such app has been developed and evaluated. The Grief Coach app will be based on the smartphone app PTSD Coach. A Swedish version of the PTSD Coach has been developed and a pilot study has been conducted as well as an ongoing RCT. Consultant programmers at Uppsala University will develop the mobile app. The content of the app will be developed together with experts in the field of grief, inspired by other grief apps and CBT therapy manuals, to modify parts of the PTSD Coach app to grief.

The main aim of this study is to examine the effectiveness of the app My Grief as compared to a waiting list comparison in reducing symptoms of prolonged grief in bereaved parents. The primary hypothesis is that the parents in the intervention group will report decreased levels of prolonged grief symptoms after having used the app. A second aim is to examine the effect of the app on related mental health problems (posttraumatic stress symptoms, depression symptoms, quality of life) and cognitive behavioral variables putatively explaining the effect of CBT techniques (i.e., grief avoidance, grief rumination and negative grief cognitions). The secondary hypotheses are that the parents in the intervention group will report improved mental health (i.e., lower symptom levels of depression and posttraumatic stress, higher quality of life), and lower grief avoidance, grief rumination, negative grief-related cognitions. A third aim is to evaluate the feasibility of the app, including participant satisfaction, evaluation of the app's strengths and weaknesses, and adverse events.

Potential participants are identified using the Swedish Childhood Cancer Registry, the Cause of Death Registry, and the Swedish Population Register at the Swedish Tax Agency. By linking the Cause of Death Registry with the Swedish Childhood Cancer Registry, children diagnosed with a malignancy and who died due to the malignancy 1 to 10 years previously will be identified. Next, the children's parents/caregivers are identified through the Swedish Population Register and will be sent a letter with an invitation to participate in the study. Participants will complete a web based pre-assessment and then given access to the app for three months followed by a web based post-assessment and an interview via telephone regarding their experiences of using the app, with follow-ups att 6 and 12 months.

Study Type

Interventional

Enrollment (Actual)

248

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Uppsala, Sweden, 75185
        • National Centre for Disaster Psychiatry, Department of Neuroscience, Uppsala university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Parents/caregivers of children who have died of cancer, at the earliest 12 month ago
  • Have symptoms of prolonged grief (PGD)
  • Understand Swedish language
  • Have access to a smartphone

Exclusion Criteria:

  • Ongoing severe psychiatric problems (e.g. suicidal thoughts, psychosis)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Participants will complete a web based pre-assessment and then given access to the app "My Grief" for three months followed by a web based post-assessment and an interview via telephone regarding their experiences of using the app, and follow-up questionnaires.
The app will build on principles of cognitive behavioural theory and therapy (CBT) and contains four main sections: Learning, Self-assessment, Manage symptoms and Find support.
No Intervention: Waitlist controll
Participants will get access to the app after three months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change (from baseline) in Prolonged Grief Disorder-13 instrument, PG-13
Time Frame: 3, 6 and 12 months
13-item, self-rated measure of prolonged grief, total score ranges from 11 to 55, where a higher score indicates more symptoms
3, 6 and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change (from baseline) in Posttraumatic stress disorder checklist for DSM-5, PCL-5
Time Frame: 3, 6 and 12 months
20-item, self-rated measure of posttraumatic stress disorder, total score range from 0-80, and a higher score indicates more symptoms
3, 6 and 12 months
Change (from baseline) in Patient Health Questionnaire, PHQ-9
Time Frame: 3, 6 and 12 months
9-item, self-rated measure of depression, total score ranges from 0-27, and a higher score indicates more symptoms
3, 6 and 12 months
Change (from baseline) in Utrecht Grief Rumination Scale, UGRS
Time Frame: 3, 6 and 12 months
15-item, self-rated measure of grief rumination, total scores range from 15 to 75, and a higher score indicates more grief rumination
3, 6 and 12 months
Change (from baseline) in Depressive and Anxious Avoidance in Prolonged Grief questionnaire
Time Frame: 3, 6 and 12 months
9-item, self-rated measure of avoidance, total score ranges from 9-72, and a higher score indicates more avoidance
3, 6 and 12 months
Change (from baseline) in 18 items from the Grief Cognitions Questionniare, GCQ
Time Frame: 3, 6 and 12 months
18-items, self-rated measure of grief cognitions, total score ranges from 0-90, and a higher score indicates more grief cognitions
3, 6 and 12 months
Change (from baseline) in Brunnsviken Brief Quality of Life Inventory, BBQ
Time Frame: 3, 6 and 12 months
12 items, self-rated measure of quality of life, covering six different life domains, Total score ranges from 0-96, higher scores indicates higher quality of life.
3, 6 and 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of the intervention and the application
Time Frame: 3 months
Feasibility will be measured by "App Survey"
3 months
Acceptability of the intervention and the application
Time Frame: 3 months
Acceptability will be measured by "App Survey"
3 months
Participants demographics
Time Frame: 0 months
age, gender, time since loss, gender child, marital status, employment status, loss-related variables
0 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Josefin Sveen, PhD, Uppsala University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2021

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

May 8, 2023

Study Registration Dates

First Submitted

September 10, 2020

First Submitted That Met QC Criteria

September 10, 2020

First Posted (Actual)

September 17, 2020

Study Record Updates

Last Update Posted (Estimate)

May 11, 2023

Last Update Submitted That Met QC Criteria

May 9, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2020-01704

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All collected IPD

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe